Novel biotransformation and physiological properties of norursodeoxycholic acid in humans

Hepatology

Volumn 42, Issue 6, 2005, Pages 1391-1398

  Hofmann, Alan F ^a   Zakko, Salam F ^a,c   Lira, Marco ^a,d   Clerici, Carlo ^a,e   Hagey, Lee R ^a,f   Lambert, K Karel ^a,g   Steinbach, Joseph H ^a   Schteingart, Claudio D ^a,h   Olinga, Peter ^b   Groothuis, Geny M M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Clinical Research Foundation   (United States)

^d UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^e UNIVERSITY OF PERUGIA   (Italy)

^f Ovature Inc   (United States)

^g Intellisource   (United States)

^h Ferring Pharmaceuticals AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; DRUG METABOLITE; ETOMIDATE; GLUCURONIDE; GLYCINE AMIDATE; NORURSODEOXYCHOLIC ACID; NUCLEOLIN; PHOSPHOLIPID; TAURINE AMIDATE; TRACER; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

AGED; ARTICLE; BILE SECRETION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BILE LEVEL; DRUG EXCRETION; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG URINE LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MICELLE; PRIORITY JOURNAL;

AGED; BIOTRANSFORMATION; CHOLESTEROL; HUMANS; LIVER; MALE; MIDDLE AGED; NORSTEROIDS; PHOSPHOLIPIDS; URSODEOXYCHOLIC ACID;

EID: 32044462778     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20943     Document Type: Article

References (41)

1. Hofmann AF. Bile acids. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The Liver: Biology and Pathobiology, 3rd ed. New York: Raven Press, 1994:677-718.
2. Matoba, N, Une M, Hoshita T. Identification of unconjugated bile acids in human bile. J Lipid Res 1986;27:1154-1162.
3. Kannenberg F, Ellinghaus P, Assmann G. Seedorf U. Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2/sterol carrier protein-x knockout mice. J Biol Chem 1999;274:35455-35460.
4. Lindstedt S, Tryding N. On the metabolism of bishomocholic, homocholic, and norcholic acid in the rat. Arkiv Kemi 1957;11:137-144.
5. O'Maille ER, Kozmary SV, Hofmann AF, Gurantz D. Different effects of norcholate and cholate on bile flow and biliary lipid secretion in die rat. Am J Physiol 1984;246:G67-G71.
6. Nakatomi F, Kihira K, Kuramoto T, Hoshita T. Intestinal absorption and metabolism of norcholic acid in rats. J Pharmacobiodyn 1985;8:557-63.
7. Yoon YB, Hagey LR, Hofmann AF, Gurantz D, Michelotti EL, Steinbach JH. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. Gastroenterology 1986;90:837-852.
8. Palmer KR, Gurantz D, Hofmann AF, Clayton LM, Hagey LR, Cecchetti S. Hypercholeresis induced by norchenodeoxycholate in biliary fistula rodent. Am J Physiol 1987;252:G219-G228.
9. 24). HEPATOLOGY 1997;26:374-385.
10. Clayton LM, Gurantz D, Hofmann AF, Hagey LR, Schteingart CD. Role of bile acid conjugation in hepatic transport of dihydroxy bile acids. J Pharmacol Exp Ther 1989;248:1130-1137.
11. Oude Elferink RPJ, de Haan J, Lambert KJ, Hagey LR, Hofmann AF, Jansen PLM. Selective hepatobiliary transport of nordeoxycholate side chain conjugates in mutant rats with a canalicular transport defect. HEPATOLOGY 1989;9:861-865.
12. Gurantz D, Schteingart CD, Hagey LR, Steinbach JH, Grotmol T, Hofmann AF. Hypercholeresis induced by unconjugated bile acid infusion is mediated by biliary secretion and not hepatocyte retention of unconjugated bile acids. HEPATOLOGY 1991;13:540-550.
13. Cohen BI, Hofmann AF, Mosbach EH, Stenger RJ, Rothschild MA, Hagey LR, et al. Differing effects of nor-ursodeoxycholic acid or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit. Gastroenterology 1986;91:189-197.
14. Hofmann AF. The cholehepatic circulation of unconjugated bile acids: an update. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile Acids and the Hepatobiliary System. Boston: Kluwer Academic Publishers, 1993:143-160.
15. Olinga P, Slooff MJH, Meijer DKF, Groothuis GMM. Liver slices in in-vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicology In Vitro 1998;12:77-100.
16. de Kanter R, de Jager MH, Draaisma AL, Jurva JU, Olinga P, Meijer DKF, et al. Drug metabolising activity of human and rat liver, lung, kidney, and intestine slices. Xenobiotica 2002;32:349-362.
17. Olinga P, Merema MT, MJH Slooff MJH, Meijer DKF, Groothuis GMM. The influence of 48 hours of cold storage in University of Wisconsin organ preservation solution on metabolic capacity of rat hepatocytes. J Hepatol 1997;27:738-743.
18. 13C-labeled bile acids using formyl esters and modified lead tetra-acetate procedure. J Lipid Res 1977;18:400-403.
19. + mRNA. Biochem Biophys Res Commun 1992;186:l455-1462.
20. 3H]-cholic acid as a stable tracer through conversion to deoxycholic acid in human subjects. J Lipid Res 1996;37:431-436.
21. Subbiah MT, Kuksis A. Alkaline solvent systems for thin-layer chromatography of bile acids. J Lipid Res 1968;9:288-290.
22. Hagey LR, Odell D, Rossi SS, Crombie DL, Hofmann AF. Biliary bile acid composition of the physeteridae (sperm whales). Marine Mammal Sci 1993;9:23-33.
23. Blankaert N, Kabra PM, Farina FA, Stafford BE, Marton LJ, Schmid R. Measurement of bilirubin and its monoconjugates and diconjugates in human serum by alkaline methanolysis and high-performance liquid chromatography. J Lab Clin Med 1980;96:198-212.
24. Turley SD, Dietschy JM. Re-evaluation of the 3α-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978;19:924-928.
25. Gurantz D, Laker MF, Hofmann AF. Enzymatic measurement of choline-containing phospholipids in bile. J Lipid Res 1981;22:373-376.
26. Cowen AE, Korman MG, Hofmann AF, Cass OW, Coffin SB. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation. Gastroenterology 1975;69:67-76.
27. Schmassmann A, Fehr HF, Locher J, Lillienau J, Schteingart CD, Rossi SS, et al. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans. Gastroenterology 1993;104:1171-1181.
28. Roda A, Hofmann AF, Mysels KJ. The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem 1983;258:6362-6370.
29. Hofmann AF. The function of bile salts in fat absorption: the solvent properties of dilute micellar solutions of conjugated bile salts. Biochem J 1963;89:57-68.
30. van Berge Henegouwen GP, Hofmann AF. Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. Gastroenterology 1978;75:879-885.
31. Danzinger RG, Nakagaki M, Hofmann AF, Ljungwe EB. Differing effects of hydroxy-7-oxotaurine-conjugated bile acids on bile flow and biliary lipid secretion in dogs. Am J Physiol 1984;246:G166-G172.
32. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, et al. Steroid and bile acid conjugates are substrates of human multidrug-resistant protein (MRP)4 (ATP-binding cassette C4). Biochem J 2003;371:361-367.
33. Rudolph G, Kloeters-Plachky P, Sauer P, Stiehl A. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate. Eur J Clin Invest 2002;32:575-580.
34. Boyer JL, Bloomer JR. Canalicular bile secretion in man. Studies utiliizing the biliary clearance of (14C) mannitol. J Clin Invest 1974;54:773-781.
35. Ko J, Hamilton JA, Ton-Nu H-T, Schteingart CD, Hofmann AF, Small DM. Effects of side chain length on ionization behavior and transbilayer transport of unconjugated dihydroxy bile acids: a comparison of nor-chenodeoxycholic acid and chenodeoxycholic acid. J Lipid Res 1994;35:883-892.
36. Crawford JM, Mockel GM, Crawford AR, Hagen SJ, Hatch VC, Barnes S, et al. Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J Lipid Res 1995;36:2147-2163.
37. Broderick AL, Hofmann AF, Carey MC. Correcting biliary phenotype in cystic fibrosis mice: norursodeoxycholic acid but not UDCA normalizes hepatic bile pH and increases bile flow in G1551D CF mice [Abstract]. HEPATOLOGY 2002;36(Pt 2):337A.
38. Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovsky O, et al. 24-norUrsodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis in mdr2 (ABCB4) knockout mice. Gastroenterology 2005 (in press).
39. Bolder U, Trang NV, Hagey LR, Schteingart CD, Ton-Nu H-T, Cerrè C, et al. Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats. Gastroenterology 1999;117:962-971.
40. Leuschner M, Holtmeier J, Ackermann H, Leuschner U. The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. Eur J Gastroenterol Hepatol 2002;14:1369-1376.
41. Collins JM. Inter-species differences in drug properties. Chem Biol Interact 2001;134:237-242.